BIOTHERYX
BioTheryX focuses on the development of therapies for hematological malignancies. It intends to leverage its extensive experience and proven commercial success to deliver efficacious therapies to patients with unmet medical needs more quickly and less expensively than the biomedical industry traditionally can and does. To do so, they are exploiting enhanced biology-driven models to identify effective core molecules that can be rapidly exploited using focused and prioritized chemistry approaches coupled with clinically proven translational approaches targeted for cancer and immune dysfunction. The company was founded in 2007 and is headquartered in Chappaqua, New York.
BIOTHERYX
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2007-01-01
Address:
Chappaqua, New York, United States
Country:
United States
Website Url:
http://www.biotheryx.com
Total Employee:
51+
Status:
Active
Contact:
(914) 490-5425
Email Addresses:
[email protected]
Total Funding:
128.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investors List
Deep Track Capital
Deep Track Capital investment in Series E - BioTheryX
Lumira Ventures
Lumira Ventures investment in Series E - BioTheryX
SR One
SR One investment in Series E - BioTheryX
Janus Henderson Investors
Janus Henderson Investors investment in Series E - BioTheryX
Rock Springs Capital
Rock Springs Capital investment in Series E - BioTheryX
Farallon Capital Management
Farallon Capital Management investment in Series E - BioTheryX
Point72
Point72 investment in Series E - BioTheryX
Alexandria Venture Investments
Alexandria Venture Investments investment in Series E - BioTheryX
Tekla Capital Management
Tekla Capital Management investment in Series E - BioTheryX
Irving Investors
Irving Investors investment in Series E - BioTheryX
Key Employee Changes
Official Site Inspections
http://www.biotheryx.com Semrush global rank: 4.31 M Semrush visits lastest month: 2.65 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioTheryX"
About Us โ Biotheryx
Biotheryx is a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders, including bifunctional degraders and molecular glues.Our focus is deploying โฆSee details»
Biotheryx - Crunchbase Company Profile & Funding
Organization. Biotheryx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Biotheryx is a clinical stage biopharmaceutical company discovering and developing a portfolio of โฆSee details»
BioTheryX Company Profile | Management and Employees List
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to โฆSee details»
Biotheryx, Inc. - LinkedIn
Biotheryx is a clinical-stage biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders, including bifunctional degraders and molecular glues.See details»
2020 - Biotheryx
About BioTheryX, Inc. ... Ben-Neriah is an elected member of the European Molecular Biology Organization (EMBO), a spokesman of the International German Israeli Graduate Student โฆSee details»
BioTheryx Company Profile 2024: Valuation, Funding
BioTheryx General Information Description. Operator of a clinical-stage biopharmaceutical company intended to develop treatments to recover from life-threatening diseases. The company's therapies center on targeted protein โฆSee details»
Biotheryx - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
BioTheryX, Inc. (BioTheryX, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
SAN DIEGO, CA, USA I July 17, 2024 I Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on validated targets โฆSee details»
BIOTHERYX, INC. - VentureRadar
" BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to โฆSee details»
biotheryx โ Biotheryx
SAN DIEGO, CA. May 7, 2024 โ Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on validated targets in โฆSee details»
Biotheryx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Biotheryx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. Biotheryx has 3 current employee profiles, โฆSee details»
BioTheryX Company Profile - Office Locations, Competitors ... - Craft
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis through protein modulation. Its principal technology platform centers on targeted โฆSee details»
Biotheryx, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Biotheryx, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Working at BioTheryX - Great Place To Work®
97% of employees at BioTheryX say it is a great place to work . ... Today, our Trust Modelโข offers an unmatched opportunity to identify whatโs happening within your organization. Great โฆSee details»
2022 - Biotheryx
October 24, 2022 โ Biotheryx, Inc., a clinical stage company discovering and developing a portfolio of innovative small molecule targeted protein degraders ... He led global strategy for โฆSee details»
BioTheryX - Overview, News & Similar companies | ZoomInfo.com
May 25, 2023 Who is BioTheryX. BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and โฆSee details»
Left out of SPAC pack, BioTheryX raises $92M in rare series E to โฆ
May 21, 2021 BioTheryX hauled a $92 million series E on Thursday led by Farallon Capital Management with backing from nearly a dozen other new investors and participation from โฆSee details»
BioTheryX Announces Appointment of Philippe Drouet as Chief โฆ
Oct 28, 2021 BioTheryX, Inc., a clinical-stage company focused on targeted protein degradation to create life-saving medicines, today announced the appointment of Philippe Drouet as โฆSee details»
Our Science - Biotheryx
Biotheryxโs PRODEGY platform: powering the next generation of targeted protein degradation Our Science ++ Overview Our founders are pioneers in the field of protein degradation , having led โฆSee details»